Common Contracts

EX-10.52 9 d912920dex1052.htm EX-10.52 Execution Version STRICTLY CONFIDENTIAL [***] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission...

Asset Purchase Agreement • May 5th, 2020 • Delaware

• Contract Type
  Asset Purchase Agreement
• Filed
  May 5th, 2020
• Jurisdiction
  Delaware

This ASSET PURCHASE AGREEMENT (this “Agreement”), is made as of February 4, 2015, by and among Forest Laboratories, LLC, a Delaware limited liability company and successor-in-interest to Forest Laboratories, Inc. (“Forest”), Forest Laboratories Holdings Limited, a corporation organized under the Laws of Ireland (“FLH”) and Forest Laboratories Canada Inc., a corporation organized under the Laws of Canada (collectively, with Forest and FLH, the “Sellers”, and each, a “Seller”), AstraZeneca UK Limited, a private limited company registered in England and Wales (“Purchaser”), and, solely with respect to Articles 10 and 11, Actavis plc, a public limited company organized under the laws of Ireland (“Seller Parent”). Each of the Sellers and Purchaser, and solely for purposes of Article 10 and 11, Seller Parent, may be referred to, individually, as a “Party” or, collectively, as the “Parties.”

ASSET PURCHASE AGREEMENT by and among FOREST LABORATORIES, LLC, FOREST LABORATORIES CANADA INC., and FOREST LABORATORIES HOLDINGS LIMITED as Sellers, ACTAVIS PLC, and ASTRAZENECA UK LIMITED, as Purchaser Dated as of February 4, 2015

Asset Purchase Agreement • May 11th, 2015 • Actavis PLC • Pharmaceutical preparations • Delaware

• Contract Type
  Asset Purchase Agreement
• Filed
  May 11th, 2015
• Company
  Actavis PLC
• Industry
  Pharmaceutical preparations
• Jurisdiction
  Delaware

This ASSET PURCHASE AGREEMENT (this “Agreement”), is made as of February 4, 2015, by and among Forest Laboratories, LLC, a Delaware limited liability company and successor-in-interest to Forest Laboratories, Inc. (“Forest”), Forest Laboratories Holdings Limited, a corporation organized under the Laws of Ireland (“FLH”) and Forest Laboratories Canada Inc., a corporation organized under the Laws of Canada (collectively, with Forest and FLH, the “Sellers”, and each, a “Seller”), AstraZeneca UK Limited, a private limited company registered in England and Wales (“Purchaser”), and, solely with respect to Articles 10 and 11, Actavis plc, a public limited company organized under the laws of Ireland (“Seller Parent”). Each of the Sellers and Purchaser, and solely for purposes of Article 10 and 11, Seller Parent, may be referred to, individually, as a “Party” or, collectively, as the “Parties.”